chrisvoncsefalvay/vaers-outcomes huggingface dataset:
panic attack; panic attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administered in upper arm left, administration date 10Mar2021 13:00 (Lot number: EN6208) at the age of 64 years as dose 1, single and administration date 31Mar2021 13:30 (Lot number: ER8733, Expiration Date: 31Jul2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Panic attacks" (ongoing). There were no concomitant medications. The following information was reported: PANIC ATTACK (non-serious) with onset 10Mar2021, outcome "recovered" (Mar2021), PANIC ATTACK (non-serious) with onset 31Mar2021, outcome "recovered" (Mar2021) and all described as "panic attack". Therapeutic measures were not taken as a result of panic attack, panic attack.  Additional Information: She had history of panic attacks but has not had one in 5 years. She experienced a panic attack at night on the same day of both her shots with the latest one (2nd doses) being last night. She does not know why she had a panic attack as she was not feeling nervous or anxious at all. Caller stated she wanted to know if people have experienced panic attacks with the vaccine; Caller stated she has experienced 2 panic attacks one after each vaccine. No prior vaccinations (within 4 weeks).No.  No follow-up attempts are possible. No further information is expected.
Experienced these side effects: headache - aspirin did not help, but excedrin worked okay; muscle pain, chills, mild fever.
Pt stated on the evening of March 10th he developed tenderness and redness at injection site.  When he presented to the clinic following day, redness and tenderness at injection site was still present, and extended to torso and left upper arm.  Pt also noted mild light headedness.  Pt reported no other symptoms.
Tested positive for covid with symptoms of URI and loss of taste and smell. Symptoms on 5/16/21 and positive PCR test on 5/17/2021
Itching; arm is still very sore; red rash on the arm close to the injection site and it is more on 14Apr2021.; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.) and PAIN IN EXTREMITY (arm is still very sore) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Depression and Allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Allergy, BUSPIRONE HYDROCHLORIDE (BUSPAR) for Depression, METOPROLOL for Hypertension.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.). On an unknown date, the patient experienced PRURITUS (Itching) and PAIN IN EXTREMITY (arm is still very sore). At the time of the report, PRURITUS (Itching) had resolved and RASH ERYTHEMATOUS (red rash on the arm close to the injection site and it is more on 14Apr2021.) and PAIN IN EXTREMITY (arm is still very sore) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment information was reported.    This case was linked to MOD-2021-105776 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Significant: new event, outcome of event added and second dose details provided
Hair loss in a small circular area around the size of a nickel on the back of my head  a few inches behind my left ear. Appears the same as alopecia areata. Began sometime within the month following vaccination. I have not had this symptom before.
Provider Sumary "66 y/o male with a past medical history significant for hypertension, hyperlipidemia, diabetes and OSA.  He presented to the emergency department on 06/24/2022 due to some chest discomfort and shortness of breath.  He was found to be COVID positive on admission although was not hypoxic so did not require steroids or remdesivir, was placed on symptomatic treatment.  He also was noted to have an AKI on arrival which returned to baseline with IV fluids.  Regarding his chest discomfort, EKG was negative for ischemic changes.  On further discussion patient states that this has been going on for a couple months, he intermittently gets chest pain with exertion but it goes away with rest.  During this admission patient had no further episodes of chest pain.  Given his description of symptoms he may have underlying stable angina, I have referred him to Cardiology for possible stress testing and further workup.  He will also follow up with his PCP next week.  At time of discharge patient was in stable and improved condition, he wanted to go home, all questions were answered, he was given strict return precautions to which he verbalized understanding.   Patient verbalized understanding and agreement to the above discharge plan. All questions were answered at time of discharge. "
Swollen lymph node and swelling in left armpit (same side as the shot was given). Was examined by a doctor at PCP clinic 2 days after symptoms were first noticed, at that time lymph node swelling described as walnut-sized. Said it may take a couple of weeks to completely resolve or come back in for a re-check.
tested positive for Covid; tested positive for Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 34-year-old female patient (unknown if pregnant) received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisatiThis is a spontaneous report received from a contactable reporter(s) (consumer or other non HCP). A 34-year-old female patient (unknown if pregnant) received BNT162b2 (Comirnaty), as dose 1, single (batch/lot number: unknown), as dose 2, single (batch/lot number: unknown) and as dose 3 (booster), single (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: drug ineffective (medically significant), COVID-19 (medically significant) all with onset 12Apr2022, outcome "unknown" and all described as "tested positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Apr2022) positive. Clinical Information: the reporter accompanied by her husband, her son and a friend have all been vaccinated and boosted with Pfizer COVID-19 vaccine. While vacationed together on a cruise ship the week from 05Apr2022 to 12Apr2022, they were notified on 12Apr2022 having been tested positive for COVID-19. They were therefore removed from the shipped and self-quarantined in a hotel. Since being quarantined they have all developed mild to moderate COVID-19 symptoms. Symptoms developed by patient was runny nose, congestion, cough and low-grade fever. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received on. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 12Apr2022, outcome "unknown" and all described as "tested positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Apr2022) positive.  Clinical Information: The reporter accompanied by her husband, her son and a friend have all been vaccinated and boosted with Pfizer Covid vaccine. While vacationed together on a cruise ship the week from 05Apr2022 to 12Apr2022, they were notified on 12Apr2022 having been tested positive for Covid. They were therefore removed from the shipped and self quarantined in a hotel. Since being quarantined they have all developed mild to moderate Covid symptoms. Symptoms developed by patient was runny nose, congestion, cough and low grade fever.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The lymph nodes in the injected arm (left arm), armpit are swollen, to about the size of a golf ball, it is tinder to the touch
booster; Positive rapid test followed by a positive PCR test; Positive rapid test followed by a positive PCR test/Runny nose, dry cough, tired; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old male patient received bnt162b2 (COMIRNATY), administration date Nov2021 (Batch/Lot number: unknown) at the age of 27 years as dose 3 (booster), single, administration date Apr2021 (Lot number: Unknown) at the age of 26 years as dose 2, single and administration date Mar2021 (Lot number: Unknown) at the age of 26 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. No known allergies, no covid prior vaccination.  The patient's concomitant medications were not reported. No other vaccine if four weeks. The following information was reported: IMMUNISATION (medically significant) with onset 15Dec2021, outcome "recovering", described as "booster"; DRUG INEFFECTIVE (medically significant) with onset 15Dec2021, outcome "unknown", described as "Positive rapid test followed by a positive PCR test"; COVID-19 (medically significant) with onset 15Dec2021, outcome "recovering", described as "Positive rapid test followed by a positive PCR test/Runny nose, dry cough, tired". The patient underwent the following laboratory tests and procedures: sars-cov-2 antibody test: (15Dec2021) positive, notes: Nasal Swab; sars-cov-2 test: (15Dec2021) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of covid-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
SHORTNESS OF BREATH; VERY TIRED, FEEL WIPED OUT; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unk) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced shortness of breath, and very tired, feel wiped out. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the very tired, feel wiped out and shortness of breath was not reported. This report was non-serious. This case, from the same reporter is linked to 20210436940.; Sender's Comments:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Began with headache and sore sinus, increase fatique, night sweats followed with exhaustion on Sunday, sick from work on Monday, Tuesday lymph nodes in neck swollen and I went to urgent care center,  tested for mono, streph which was negative, sent for CBC to rule out lymphoma because my neck lymph nodes were so swollen, exhaustion continued,  Thursday sudden flashes in eye and blurred vision.  Went to see ophthalmologist that afternoon at 3 pm. Sick from work on Friday,  I feel I was very healthy befor receiving the flu shot and after receiving it, I has such a inflammatory response to it  I have been sick since.  I still have vision problems and exhaustion  I have voiced issues with taking the flu shot to my manager and occupational health in past.  It is mandatory at my job or else we have to wear a mask for flu season.
Severe sore throat; Nasal congestion; Body aches; Dry cough; Mid-grade fever; Lethargy; Symptomology very similar to typical flu; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 09:15 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no allergies to medications, food or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 13:00, the patient experienced severe sore throat, nasal congestion, body aches, dry cough, mid-grade fever, lethargy and symptomology very similar to typical flu. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events severe sore throat, nasal congestion, body aches, dry cough, mid-grade fever, lethargy and symptomology very similar to typical flu was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
my periods became irregular and I am experience breakthrough irregular bleeding throughout my cycle as well as very painful and heavy periods.; breakthrough irregular bleeding throughout my cycle as well as very painful and heavy periods.; As well as very painful and heavy periods; heavy periods.; This is a spontaneous report from a contactable consumer or other non hcp (patient).  A 34-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Ew 0172, Expiration date: not reported) via an unspecified route of administration, administered in Arm Left on 22Apr2021 at 14.00 (at the age of 34-years-old) as dose 2, single for covid-19 immunization at Pharmacy or Drug Store. Patient was not pregnant at time of Vaccination. The patient's medical history and concomitant medications were not reported. The patient previously took Biaxin and experienced drug allergy. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER 8730, Expiration date: not reported) via an unspecified route of administration in left arm, on 01Apr2021 at 14.00 (at the age of 34-years-old) as dose 1, single for covid-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. Patient did not receive within 2 weeks of vaccination. The patient reported that, on 01May2021 since i have had the vaccine my periods became irregular, and I am experience breakthrough irregular bleeding throughout my cycle as well as very painful and heavy periods. No Hospitalization was required. Event resulted in the Doctor or other healthcare professional office/clinic visit. Device date was reported as 19Jul2021. The outcome of all the events was not resolved.  Follow-up attempts are completed. No further information is expected.
Patient brought to the ED by EMS on 11/28/22 for shortness of breath, weakness, cough, and nasal congestion. Per EMS report, patient had blood oxygen of 85% so was placed on 4L en route. COVID PCR test done in the ED on 11/28 resulted positive. Patient admitted 11/28/22 - 11/30/22 for acute respiratory failure with hypoxia, pneumonia due to COVID-19, among other problems. Patient was weaned off O2 quickly and was able to be on room air.
My Dad was healthy no symptoms on first shot . On Second shoot just slight pain in arm ,  he felt sick on Sunday the 4 of April  at around 7pm he had a upset stomach. He got worse at night. in the morning Monday the 5 April we decided it was time to take him to the hospital. Due to the covid 19 restriction we were not able  to go in with him He was stable until 1 pm when he suffered 4 heart attacks . He Died .  He was healthy he exercise and was active every day . We were told to report this because it was close to dates of vaccination.
Pt recvd vax & 4 days later devel constipation which was accompanied by cramps; pt was also lightheaded, tired, disoriented, noted a sl inc in blood sugar levels; constipation lasted for 5 days; MD treated w/DPH & Rowasa enemas w/relief;
Received HPV vaccine. Standing at check in desk and indicated he felt hungry. Began to go down to floor and was eased to floor by staff. Per a person responding the patient was unresponsive so he requested a code blue adult be called. Called immediately. Patient unresponsive for 2-3 seconds. Woke with a sternal rub. When woke indicated he did not know how he got down to floor. Skin diaphoretic. Skin pale. BP 98/62. HR 88. Code Blue team on site within 2 minutes.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies: sulfa drugs" (unspecified if ongoing); "author-immune disease" (unspecified if ongoing). The patient's concomitant medications were not reported and also reported as it was unknown if patient took other medication in 2 weeks. The following information was reported: COVID-19 (medically significant) with onset 19Jun2022, outcome "not recovered", DRUG INEFFECTIVE (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Jun2022) negative, notes: 4 days after starting paxlovid I had a negative home test; (18Jun2022) Negative, notes: another negative test 6 days after starting; (19Jun2022) Positive, notes: Tested positive for Covid again (3 days after Paxlovid finished). Therapeutic measures were taken as a result of drug ineffective, covid-19 covid-19 included Paxlovid started on 12Jun2022 and stopped on 16Jun2022. Clinical course was reported as, 4 days after starting Paxlovid patient had a negative home test and another negative test 6 days after starting. On the 9th day she got a head cold and bad body aches. Tested positive for Covid again (3 days after Paxlovid finished) on 21Jun2022. No treatment received for symptoms and patient was not recovered from symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Both arms legs and tongue started going numb and vision gets blurry and feeling like I am going to faint. Started about 10 days after vaccine and happened several times a day for 2 weeks. Then it didn't happen for 7 days and came back 1 time. Now it's been almost 3 weeks with no occurrences until the last 2 days and its really bad this time.
Red circle progressively getting bigger around injection site. Pain, redness, swelling. Skin around injection site is warm and firm. Extreme tiredness as well.
It was reported that a female pt received a YF vax on 8/16/00 and approximately 18 hours, post vax, she developed light-headedness, nausea and slight dizziness, lasting only 8 hours.
Dad reports redness and swelling to RD 12/20/02. Weakness to extremity and pain with movement such as lifting arm. Dad called on 12/23/02 to follow up, Dad not at home, however Grandmother states child doing better. Child returned on 1/28/03 for immunizations. Dad states pt doing fine. Dad requested VAER be filed.
Fever, chills, headache, body ache appx 12-36 hours after receiving 2nd dose  Red splotches on stomach and creeping to back, arms, and legs several days after receiving 2nd dose Rash is persistent after 20+ days
Pt recvd 2 doses of Engerix-B & w/in 30 minutes of 2nd inject devel flushing, tired, nausea, vomiting, & diffuse abdo pain;
Patient's arm was sore, it swelled to twice it's normal size, and was itchy. This happened the evening of the shot, around 1 or 2 PM. By 9 AM the next day, patient was already feeling better.
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L30A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HERPES ZOSTER (shingles). The patient was treated with ACYCLOVIR [ACICLOVIR] for Adverse event, at a dose of UNK dosage form. At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Can't stop shivering with chills even in hot tub with heater on in room, headache, sore arm, metallic nasty taste mouth, cough, fatigue
he hasn't slept for days; tinnitus has gotten worse since the 1st dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose 1, single for covid-19 immunisation. Relevant medical history included: "Tinnitus" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INSOMNIA (non-serious), outcome "unknown", described as "he hasn't slept for days"; TINNITUS (non-serious), outcome "unknown", described as "tinnitus has gotten worse since the 1st dose". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
diarrhea; nausea; vomiting; headaches; This is a Spontaneous report received from a contactable physician. A male patient of an unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. the reporter has a patient who is supposed to come for his 2nd dose of the COVID19 Vaccine but has diarrhea, nausea and vomiting, and headaches. She is asking if she should delay the dose for the patient. She mentioned that he got tested and has shown no symptoms of COVID. Events outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recvd vax 12NOV92 & 30NOV92 pt devel muscle weakness & pain in neck, shoulders, arms & legs; pain progressed to achiness & stiffnes; also devel cold hands & feet;